JCRB4109 NCC-dCS1-C1

Cell information

Important Notice(s)

Culture medium and substratum for NCC-series of sarcoma cell lines / NCCシリーズ肉腫細胞株の培地と培養基質

NCCシリーズ肉腫由来細胞株の分譲について:営利機関への分譲には細胞樹立機関である国立がん研究センターとの有体物提供契約書の締結が必要です

Conclusion of Material Transfer Agreement with charge (MTA) with National Cancer Center (NCC) is prerequisite for the transfer of NCC-series of sarcoma-derived cell lines to For-profit Organizations.

Cell type:general cells (View Pricing Information)

JCRB No.   JCRB4109 Cell Name   NCC-dCS1-C1
Profile   dedifferentiated chondrosarcoma cellline Other Name   
Animal   human Strain   
Genus   Homo Species   sapiens
Sex   F Age   65-year-old
Identity   available Tissue for Primary Cancer   Right Chest
Case history   dedifferentiated chondrosarcoma Metastasis   
Tissue Metastasized    Genetics   homozygous deletion of CDKN2A and CREBBP
Life Span   Not confirmed Crisis PDL   
Morphology   Spindle-shape Character   doubling time: 29 hr
Classify   tumor Established by   Reiko OYAMA
Registered by   Tadashi KONDO Regulation for Distribution   Additional MTA (for profit organization)
Comment    Year   2024
Medium   Original medium: DMEM/F-12 medium with 10% FBS. (Current medium for propagation: DMEM/F-12 medium supplemented with GlutaMAX, 5% heat-inactivated fetal bovine serum (FBS), 10 uM Y-27632, 10 ng/mL basic fibroblast growth factor (bFGF), 5 ng/mL epidermal growth factor (EGF), 5 ug/mL insulin, 0.4 ug/mL hydrocortisone.) Methods for Passages   Trypsin-EDTA
Cell Number on Passage    Race   Japanese
CO2 Conc.   5% Tissue Sampling   Chest
Tissue Type   

Detection of virus genome fragment by Real-time PCR
Detected DNA Virus not tested Detected RNA Virus not tested

Reference
Pubmed id:30737713Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Oyama R,Kito F,Takahashi M,Sakumoto M,Shiozawa K,Qiao Z,Noguchi R,Kubo T,Toki S,Nakatani F,Yoshida A,Kawai A,Kondo T
Hum Cell. 2019 Apr;32(2):202-213

Images
Movies



LOT Information

Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.
Cell No.   JCRB4109 Cell Name   NCC-dCS1-C1
LOT No.   12112025 Lot Specification   distribution
Medium   DMEM/F12 supplemented with GlutaMax(GIBCO #10565018) with 5% heat-inactivated fetal bovine serum (Nichirei Cat. # 174112, Lot 20M00K), 5 ug/mL insulin, 0.4 ug/mL hydrocortisone, 5 ng/mL EGF, 10 ng/mL bFGF and 5 uM Y-27632.Collagen coat plate used. Temperature   37 C
Cell Density at Seeding   0.58-1.79x10^4cells/sq.cm Methods for Passages   Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA.
Doubling Time   NT Cell Number in Vial (cells/1ml)   1.53x10^6
Viability at cell freezing (%)   85.02 Antibiotics Used   free
Passage Number   p29 PDL   NT
Sterility: MYCOPLASMA   - Sterility: BACTERIA   -
Sterility: FUNGI   - Isozyme Analysis   NT
Chromosome Mode   NT Chromosome Information   NT
Surface Antigen   NT DNA Profile (STR)   D5S818:10,11
D13S317:10
D7S820:10,12
D16S539:10
VWA:16
TH01:9
AM:X
TPOX:8
CSF1PO:10,12
Adhesion   Yes Exoteric Gene   NT
Medium for Freezing   BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) CO2 Conc.   5%
Viability immediately after thawing (%)   94.41 Additional information   Collagen coat plate used.
Images
CLOSE